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Abstract  
The rise in rates of opioid addiction among women of childbearing age, alongside the 
consistent rates of unintended pregnancy, has changed the landscape for the public health risks 
and outcomes of unintended pregnancies in the United States. Concurrently, uptake of long-
acting reversible contraception (LARC) remains low among all women, particularly those with 
substance use disorder. This project explores the perceived barriers to LARC among women 
enrolled in medication-assisted treatment (MAT) for opioid addiction. A mixed methods, cross-
sectional survey design was used to capture how women in MAT access care, their reproductive 
planning and intention, contraceptive knowledge and behavior, and their perceived barriers to 
LARC. Of the 50 women interviewed, 84% experienced at least one unintended pregnancy in her 
lifetime. Although approximately 75% of women indicated awareness of both the IUD and 
implant, only 6% reported the use of either of these devices. A total of 21 themes related to the 
likelihood of LARC uptake were identified among free-text responses. Of these, the greatest 
barriers to the uptake of LARC were women’s expressed fears of complication related to LARC 
use, and the myths propagated by the relationship influences of family, friends, and 
acquaintances. The design and implementation of grassroots LARC marketing could replace or 
mute the misinformation and cautionary advice that seems to be cultivated along the social 
grapevine. Frequent, often daily, contact with the healthcare system for women within 
medication-assisted treatment facilities provides an excellent avenue for improved access to 
appropriate LARC information alongside the provision of appropriate resources for reproductive 
health. Integrating these services aligns with current recommendations for comprehensive care of 
women seeking treatment for SUD and can serve to support each woman’s commitment to 
sustained recovery by promoting both contraceptive choice and reproductive autonomy. 
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Introduction and Background 
Despite the development of many safe, affordable, and effective family planning services, 
approximately half of all reported pregnancies in the United States are unintended (CDC, 2015). 
In the year 2010, public costs of births resulting from unintended pregnancies were an estimated 
$21.0 billion (Sonfield &Kost, 2015). As such, the improvement of pregnancy planning and 
spacing, and the prevention of unintended pregnancies remain top objectives of Healthy People 
2020 (ODPHP, 2017). Support and enhancement of family planning services within the United 
States not only provides women and their families with increased control over their future, but 
also preserves government funding by saving nearly $4 in pregnancy-related Medicaid 
expenditures for every $1 spent in prevention (ODPHP, 2017). 
Further complicating the health of women living in the United States, is the epidemic rise 
in rates of opioid addiction and overdose. The death of women by overdose from prescription 
painkillers increased by 400% from 1999 to 2010, and the use of heroin increased 100% between 
2002 and 2013 (U.S. Department of Health and Human Services Office on Women’s Health 
[OWH], 2016). From 2007 to 2012, The National Surveys on Drug Use and Health (NSDUH) 
indicate an increase in opioid misuse among women who were pregnant and between the ages of 
15 to 44 years (SAMHSA, 2017). The rise in rates of opioid addiction among women of 
childbearing age, alongside the consistent rates of unintended pregnancy, has changed the 
landscape for the public health risks and outcomes of unintended pregnancies in the United 
States.  
As this trend continues, there is a parallel mortality and morbidity related to newborn 
infants with Neonatal Abstinence Syndrome (NAS). NAS is a constellation of health problems-
including diarrhea, poor feeding, seizures, sleep problems, slow weight gain, and tremors, that 
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occur in newborns exposed to opiate drugs during pregnancy (McQueen & Murphy-Oikonen, 
2016; Lee, 2015).  In addition to the health effects on the infant, NAS increases maternal stress 
in perinatal and postpartum periods (Corr & Hollenbeak, 2017; Velez & Jansson, 2008).  
These public health issues are prevalent nationwide, and the state of Tennessee has the 
second highest opioid prescribing rate per capita in the nation. In 2012 it was estimated that 
69,100 individuals were addicted to opioids, with prescription-related deaths totaling nearly 
1,300 in 2014 (Stewart, 2016). In 2014, women in Tennessee, ages 25 to 44 years, had higher 
rates of inpatient hospital stays and emergency department visits related to opioid use compared 
men (Weiss et al., 2017). Additionally, almost half of the pregnancies in Tennessee from 2011 
were reported as unintended. Among those that were trying to avoid pregnancy, over one-half 
were not using birth control (Tennessee Department of Health, 2011). The confluence of these 
public health issues has contributed directly to an incidence of NAS in the state of Tennessee that 
has increased 15-fold over the last decade, amounting to 973 cases of NAS in 2014. The cost for 
increased care of these newborns amounted to nearly $48 million in healthcare expenditures 
(Stewart, 2016). Compared to the 3-fold increase of NAS within the United States as a whole, it 
is apparent that Tennessee has a particular need for public health interventions related to both 
prevention of unplanned pregnancy and treatment of substance use disorder (SUD) in women of 
childbearing age. The primary prevention of unintended pregnancies creates an opportunity for 
secondary prevention of neonatal abstinence syndrome for babies born to women with substance 
use disorder. 
Increasing access to reliable and effective contraceptive options for all women of 
childbearing age is one such intervention. To effectively prevent unintended pregnancy, the 
American College of Obstetricians and Gynecologists (ACOG) and the American Academy of 
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Pediatrics (AAP) advocate for increased access to contraceptive implants and intrauterine 
devices (IUDs), otherwise known as long-acting reversible contraception (LARC). While 
implants and IUDs are not new devices, a lag in their uptake within the United States has 
persisted since their introduction in the 1960’s (Strasser, Borkowski, Couillard, Allina & Wood, 
2016). LARC is the most reliable and effective form of birth control, second only to sterilization. 
However, only 7.2% of women in the U.S., between the ages of 15 and 44, are currently using 
LARC (Daniels, Daugherty, Jones & Mosher, 2015). Given that women with substance abuse 
disorder related to opioid addiction have higher rates of unplanned pregnancies compared to 
women who do not use drugs, one might assume that rates of LARC use among this particular 
population are similar to, if not lower than, the aforementioned rates within the United States 
(Terplan, Hand, Hutchinson, Salisbury-Afshar & Heil, 2015). Therefore, increasing the uptake of 
LARC among all women of reproductive age may have an added benefit in the subpopulation of 
women with substance use disorder, by decreasing both unintended pregnancies and the myriad 
health consequences, including NAS, related to fetal exposure to illicit substances in utero.  
Problem Statement 
Though LARC devices are considered first-line for the reduction of unintended 
pregnancies, rates of LARC uptake remain low in this country for reasons that are not well 
understood. Additionally, there is little in the literature regarding the use of LARC to reduce the 
rates of unintended pregnancies within a population of women who experience substance abuse 
disorder. Specifically, little is mentioned regarding the introduction of the option of LARC to 
women in treatment for opioid addiction as a way to prevent unintended pregnancies and 
subsequently decrease the rates of neonatal abstinence syndrome in the United States.  
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Purpose 
The purpose of this study was to identify the perceived barriers to long-acting reversible 
contraception (LARC) among women of childbearing age enrolled in medication assisted 
treatment for opioid addiction.  
Review of Evidence 
The intrauterine device (IUD), both hormonal and non-hormonal, as well as the contraceptive 
implant, tout efficacy rates of less than one pregnancy per 100 women in one year, a rate 
comparable to the permanent method of sterilization, or tubal ligation (ACOG, 2015). These 
devices maintain their effectiveness due to a one-time insertion process that eliminates user 
dependence and error from the efficacy equation (ACOG, 2015; Parks & Peipert, 2016). In 
contrast, the most commonly used contraceptive method, the oral contraceptive pill, has an 
estimated 9% contraceptive failure rate within the first 12 months of typical use (Daniels et al., 
2015). The male condom, used by approximately 5.8 million women as a primary form of 
pregnancy prevention, carries an 18% failure rate within the same time period. These 
contraceptive failures are attributed to inconsistent or incorrect use of these birth control methods 
(Daniels et al., 2015). 
Recent recommendations for the use of LARC have expanded beyond previously specified 
health populations to include adolescent girls, women who are nulliparous, and women who 
living with chronic medical conditions, like certain cancers and HIV, for whom pregnancy could 
contribute to known health risks associated with disease progression (ACOG, 2015; AHA Media, 
2017). Increased access to LARC for all women has the potential to lower the rates of 
unintended pregnancies, and thereby mitigate the risks of maternal depression, low-birthweight 
infants, low education and income levels, and higher rates of intimate partner violence (Parks & 
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Peipert, 2016). Some believe these devices should be offered to women who experience 
substance use disorder related to opioid addiction, in an effort to assist those seeking to control 
their own family planning patterns and protect their recovery (Harding & Ritchie, 2003; Krans, 
Cochran, & Bogen, 2015; Patrick & Schiff, 2017; Terplan et al., 2015).  
Unique Barriers to LARC  
 Although barriers to LARC exist for all women in the United States, women with 
substance use disorder face a unique set of challenges that increase their risk for unintended 
pregnancy and their vulnerability to the poor outcomes associated with it (Black et al., 2012; 
Patrick et al., 2017; Terplan et al., 2015).. One study found that eight in ten women with SUD 
who had ever been pregnant reported at least one unintended pregnancy, a rate significantly 
higher than the national average in the United States (Terplan et al., 2015). These higher rates of 
unintended pregnancy may be attributed to high risk behaviors associated with the misuse of 
prescription and street drugs.  
 In addition, women who are addicted to opioids and experience an unplanned pregnancy 
are at high risk for preterm birth, low birth weight infants, and infants born with neonatal 
abstinence syndrome (Black et al., 2012; Patrick et al., 2017; Terplan et al., 2015). These same 
risks are found in women who are in medication-assisted treatment (MAT) for opioid addiction.  
It is expected that babies born to women using prescribed methadone or buprenorphine treatment 
will experience symptoms of NAS during the neonatal period (Velez & Jansson, 2008). These 
outcomes may create stress for any woman, let alone those with the additional burden of 
substance abuse disorder. It is widely accepted that the postpartum period is stressful for most 
women. As stress is a known trigger for relapse, women are often at increased risk of relapse and 
overdose during this time (ASAM, 2017; Velez & Jansson, 2008). These outcomes not only 
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increase the burden of stress and guilt for women and their families, but also increase costs to the 
families, hospitals, and states (Velez & Jansson, 2008).  
Additional barriers to LARC such as cost, physician bias, knowledge gaps, and decreased 
access to care, present a challenging scenario for women seeking reproductive autonomy and 
greater control over their reproductive health. Increased access to programs that promote positive 
reproductive health may encourage intentional engagement in healthcare services, and the 
opportunity for control over health-related choices. Women involved in MAT often have access 
to more consistent points of care as they interact with providers for medication adjustment and 
psychological therapy. Studies indicate that women in these settings have the opportunity for 
consistent family planning counseling and patient-centered education on the availability of 
contraceptive devices, including long-acting contraception (Black et al., 2012; Patrick et al., 
2017; Terplan et al., 2015). At a minimum, the American Society of Addiction Medicine 
(ASAM) (2017) recommends that all women seeking substance use disorder treatment should be 
screened for 12-month pregnancy intention, at intake, and offered referrals to comprehensive 
family planning services, including contraception.  
As these scenarios continue to present themselves, opportunities arise for healthcare 
providers and public health officials to create patient-centered family planning services that are 
appropriate and readily available to women in outpatient treatment for substance abuse disorder. 
A clear understanding of the perceived barriers to the uptake of LARC can inform the 
development of patient-centered family planning services that integrate easily into a model of 
sustained recovery for women. 
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Generalized Barriers to LARC 
 Gaps in appropriate LARC knowledge and common misconceptions of these devices 
remain a significant barrier to LARC uptake among all women. The association of early era 
IUDs and implants with high rates of negative side effects, pelvic inflammatory disease (PID), 
infertility, miscarriages, and hospitalizations has continued to pepper the current LARC 
environment with thoughts of harm and mistrust (Russo et al., 2013; Strasser et el., 2016). Other 
patient misconceptions regarding the use of LARC include ideas that these devices cause 
abortion, infertility, ectopic pregnancy, and menstrual irregularities (Russo et al., 2013). These 
misunderstandings are not limited to patients but reflect the perception of some providers as 
well. Studies indicate some providers continue to have overly restrictive criteria for LARC 
insertion, excluding women with a history of PID, ectopic pregnancy, or nulliparity (Higgins et 
al., 2016; Strasser et al., 2016). Still other providers reported negative attitudes about certain 
contraceptive methods as well as lack of knowledge, training, and comfort inserting and 
managing these devices (Akers, et al., 2010; Strasser et al., 2016). Awareness of these common 
misperceptions highlights an opportunity for advocacy as well as patient and provider education 
related to the actual risks and benefits of LARC insertion and maintenance (ACOG, 2015). 
Breaking Down Barriers  
 While existing barriers perpetuate the low rate of LARC uptake by women in the United 
States, statewide initiatives including patient and provider education programs, contraceptive 
cost reductions, marketing strategies, and public outreach are increasing awareness of LARC 
within patient populations, decreasing provider resistance to LARC provision, and eliminating 
the prohibitive cost barrier (Birgisson, Zhao, Secura, Madden & Peipert, 2015; Goldwaithe, 
Duca, Johnson, Ostendorf & Sheeder, 2015; Sundstrom, et al., 2016; Strasser et al., 2016).  The 
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Iowa Initiative, Colorado Initiative to Reduce Unintended Pregnancy (Colorado Initiative), and 
the CHOICES project in St. Louis, Missouri, seek to increase access to family planning services 
through grants and other sources of government funding. These monetary awards decrease the 
prohibitive costs of LARC devices for patients, and fund the education and training of providers 
in Title X clinics and other family planning sites that serve low-income women without access to 
reproductive health care (Birgisson et al., 2015; Goldwaithe, et al., 2015; Strasser et al., 2016). 
Additionally, programs in the states of Iowa and South Carolina allocate funding towards 
marketing and outreach for LARC, and the promotion of family planning clinics in general 
(Strasser et al., 2016, Sundstrom et al., 2016). The success of these programs is demonstrated in 
a strong correlation between the increase of LARC use among women of childbearing age and 
subsequent declines in the rates of unintended pregnancies, shortened pregnancy intervals, 
preterm births, low-birthweight infants, and associated healthcare costs related to these outcomes 
(Birgisson et al., 2015; Goldwaithe, et al., 2015; Strasser et al., 2016;  Sundstrom et al., 2016). 
Theoretical Model 
 The Health Belief Model (HBM) was developed in the 1950s by a group of psychologists 
who sought to understand the reasoning behind the decreased uptake of preventative screenings 
and health behaviors in the United States (Janz & Becker, 1984). The model was founded upon 
assumptions strongly based in psychological and behavioral theory. These assumptions include 
the idea that health behavior is dependent upon an individual’s desire to avoid illness, and on his 
or her belief that a specific health action will prevent or cure an illness (Janz & Becker, 1984). 
The decision of whether or not to perform a health behavior is influenced by six constructs found 
within the HBM.  
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 Key constructs of the HBM include; perceived susceptibility, perceived severity, 
perceived benefits, perceived barriers, cues to action, and self-efficacy. Each construct 
individually affects the likelihood of whether or not an individual will engage in a health-
promoting behavior. Figure 1 represents a visual depiction of the influential relationship between 
each construct and the probability that one will enact a health-promoting behavior 
(Dadgarmoghaddam, M. et al., 2016).  
 Often, the initial push towards engaging in a health-promoting behavior is an individual’s 
perceived susceptibility to and severity of an illness. Perceived susceptibility is the risk that one 
feels he or she has of acquiring an illness or disease, otherwise described as feelings of 
vulnerability. Perceived severity refers to the individual’s feelings of how serious potential 
medical or social consequences, including death, disability, pain, or changes family life and 
social relationships could be in the event that he or she did acquire the illness in question (Janz & 
Becker, 1984). The combination of these two constructs, susceptibility and severity, creates an 
overarching concept of perceived threat, which ultimately impacts the participation in health 
behavior.  
 The concepts of perceived benefits and barriers can be equally influential in determining 
an individual’s choice of health-promoting behaviors. Perceived benefits encompass an 
individual’s views on the feasibility and efficacy of various actions as they relate to the 
prevention or cure of an illness. That is, an individual must believe that a specific course of 
action will succeed in thwarting the undesired illness from developing (Janz & Becker, 1984). In 
contrast, perceived barriers, including cost, side effects, and inconvenience, are often weighed 
against any perceived benefits to determine whether a specific health action merits an attempt 
(Janz & Becker, 1984).  
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 Cues to action are the stimuli needed for an individual to accept a recommended health 
action. These stimuli may be internal, including symptoms of an illness such as coughing, pain, 
and shortness of breath, or they may be external, including advice from others, and stories heard 
in the news (Janz & Becker, 1984). Once these cues are received, an individual must also believe 
that he or she can successfully perform the recommended health behavior. The construct of self-
efficacy accounts for one’s level of confidence in accomplishing this goal (Janz & Becker, 
1984).  
Application of Theoretical Model 
The use of long-acting reversible contraception is touted as one of the most effective 
health behaviors available for the prevention of unintended pregnancy (ACOG, 2015). However, 
low rates of uptake of these devices suggest a disconnect between how women perceive the 
intended benefits of LARC and how they perceive the barriers related to the use of either device.  
The concepts found in the Health Belief Model, were used as the theoretical framework through 
which to explore and understand the perceived barriers towards LARC use among women 
receiving medication-assisted treatment for opioid addiction.  
Project Design 
A cross-sectional mixed methods survey design was used to examine the perceived 
barriers to LARC among women receiving medication-assisted treatment for opioid addiction. 
This scripted, interview-based, survey design allowed for a one-time capture of participant 
responses, which minimized non-response errors and adjusted for suspected differences in 
literacy levels within the sample population. This project was approved by the Belmont 
University Institutional Review Board. Data collection occurred between October and November 
2017. 
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Clinical Setting  
 Participant recruitment and data collection occurred at the Behavioral Health Group 
(BHG) Opioid Addiction Treatment Center in Nashville, Tennessee. BHG is a large urban 
treatment center that provides daily access to outpatient pharmacotherapeutic maintenance and 
detoxification services for men and women seeking treatment for opioid addiction. Individuals 
who seek detoxification services have access to a patient-centered treatment program including 
both Medication Assisted Treatment (MAT) using methadone or buprenorphine, and team-based 
behavioral counseling to assist with the psychological dependence aspect of opioid addiction.  
A single private office within the BHG facility was used to complete participant interviews.  
Project Population 
Participants eligible for this project were English-speaking women, ages 18 to 44 years, 
currently enrolled in treatment at BHG Nashville, who were not currently pregnant. Women who 
did not meet these criteria were excluded from the sample population.  
Of the 778 total individuals enrolled in BHG’s program at the time of the project, 330 
patients were female. There was no available data to determine how many female patients fell 
within the age parameters. However, of the total patient population, 635 men and women were 
between the ages of 18 to 49 years. At the time of the project, 12 women were listed as currently 
pregnant, and were not eligible to participate in the survey.  
Instruments 
 Data collection for this study was conducted using a scripted interview-based survey that 
included 70 questions and lasted approximately 10 minutes. The survey was adapted by the 
project leader using questions from two surveys identified separately in the literature. A detailed 
review of the adapted survey may be found in the Appendix.   
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The “LARC on College Campuses” survey was identified in a study used to explore the 
knowledge of and perceived barriers to LARC among women on college campuses (Hall, et al., 
2016). The authors of the study created a 55-item survey that uses a multi-level approach to 
measure women’s understanding of, experience with, and perceived barriers to intrauterine 
devices (IUD) and implants. The project leader used questions 15a, 15b, 15c, 16a, and 16b of the 
identified survey. These questions specifically relate to the use of and perceived barriers to 
LARC (Hall, et al., 2016).   
 In addition to the Hall et al. (2016) survey, the project leader adapted questions from 
Black and Day’s “Improving Contraception Uptake Baseline Questionnaire” (2016). This survey 
was identified within a study that explored unplanned pregnancy and contraceptive use in 
women of childbearing age, 18 to 54 years, receiving drug treatment services (Black & Day, 
2016). Questions within this survey were based on the National Survey of Sexual Attitudes and 
Lifestyles (NATSAL) in the United Kingdom. The original 89-question survey was used to 
explore questions related to sexual health, knowledge of long-acting reversible contraception, 
reproductive history, and reproductive healthcare (Black & Day, 2016). The project leader 
identified 43 questions within this survey to be adapted for the use of this project. The project 
leader included questions; 36-50, 52-60, 62-64, 68, 73, 74, 76, 78a, 80-82, and 89, in the current 
project survey. The questions address contraceptive use, sexual health, healthcare practices, 
awareness and knowledge of long acting reversible contraception, and reproductive history and 
intentions.  
Both surveys were developed and used in original exploratory research and were found to 
address key barriers and points of knowledge identified in the literature that apply to populations 
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including women of childbearing age and women receiving treatment for co-morbid substance 
use disorders.  
Demographic questions including age, education, income, marital status, health 
insurance, and ethnicity were adapted from the United States Census. Section I of the adapted 
survey tool addressed access to healthcare and healthcare practices. Section II included 
information related to reproductive history and intentions, as well as general contraceptive 
access. Section III addressed general contraceptive awareness, behaviors, and barriers to uptake. 
These questions were specifically related to the oral contraceptive pill, the condom, and the 
Depo-Provera shot, as these three methods are the most commonly used non-permanent forms of 
contraception in the United States (Guttmacher Institute, 2016). Sections IV, V, and VI 
addressed the awareness of, perceived barriers to, and uptake of the intrauterine device (IUD) 
and the implant specifically.  
The adapted survey was reviewed and revised with an expert panel comprised of a Doctor 
of Nursing Practice (DNP) with experience working directly with the patient population at BHG 
Nashville, TN, and a DNP serving as the project advisor. The revised survey was then piloted 
with a group of women of childbearing age, not in the healthcare field, to improve item clarity 
and content validity. All revisions were reviewed with the project advisor. 
Data Collection Process 
 
Prior to participant recruitment, a meeting was held with staff counselors, the Program 
Director, and Medical Director in order to brief these individuals on the premise of the project 
and appropriate inclusion and exclusion criteria. Advertising for participants was conducted in 
the form of flyers placed in communal areas of the BHG Nashville facility one week prior to data 
collection initiation. At the same time, smaller versions of these flyers, handbills, were 
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distributed to the BHG counselors to be placed on their desks for patient perusal and uptake. 
Handbills were also placed at the front desk and inside the dosing booths. Each of these 
resources directed potential participants to their dosing nurse or counselor for further instructions 
on study participation. See Appendix for an example of the advertisement flyer. 
Upon review of the flyer or handbill, volunteers were directed by their counselor or nurse 
to a private office within the building to meet with the project leader individually. The project 
leader determined the eligibility of each volunteer before obtaining written informed consent. 
Signed consent forms were stored in a lock box, which remained in the possession of the project 
leader.  
The project leader read each individual the prompt and question to the participant before 
entering responses directly into the online survey. With each participant, a new survey was 
started within the database. Survey responses were both anonymous and confidential. Upon 
completion of the interview, each participant was thanked for her time and given a $5 gift card to 
a local supermarket. This data collection process was repeated between the hours of 0530 and 
1130am, Monday through Friday for four weeks.  
Data Analysis  
Once all surveys were completed, the data was transferred directly from Qualtrics into 
IBM SPSS 23.0 statistical analysis software and Microsoft Excel to be analyzed. Frequency 
statistics were calculated to identify patterns and trends related to healthcare access, reproductive 
history, reproductive intentions, contraceptive knowledge and behaviors, and LARC awareness 
and perceptions.  
The Health Belief model was used to guide analysis and organization of the qualitative 
survey results. Themes identified in the results were organized using the constructs of the HBM 
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including; perceived benefits, perceived barriers, perceived seriousness, perceived susceptibility, 
and cues to action.  The identification of qualitative themes related to the reasons for decreased 
LARC engagement, helped to identify potential areas of improvement as they relate to the 
increased likelihood of LARC use within the sample population. 
Open-coding analysis of free-text responses was conducted to identify themes related to 
the perceived benefits and barriers to LARC uptake. The iterative process of coding took place in 
a series of three sessions in which each participant’s response was reviewed separately and key 
phrases were identified. After thorough review of each response, key phrases were then 
examined for patterns, similarities, and differences. Identification of these patterns then resulted 
in the assignment of one or more themes to each key phrase. The reflective process of memoing 
was used after each coding session to detail the process of analysis, theme assignment, and 
identification of any possible relationships between each theme. An example of the memoing 
process is found in the Appendix. All final themes were organized using the concepts of Health 
Belief Model. Those that did not fit cleanly within the concepts of the model were assigned to a 
separate category. 
Results  
 
A total of 60 women completed the eligibility survey. Of these, 5 women were not 
eligible to participate due to a reported age greater than 44 years, 4 women were ineligible 
because they were currently pregnant, and 1 woman was ineligible because she was not currently 
enrolled in the outpatient treatment program. This resulted in a final sample of 50 participants, 
all of whom completed the survey in its entirety. Table 1 provides a full report of participants’ 
demographic characteristics. 
 
Running header: PERCEIVED BARRIERS TO LARC 
 
19 
Quantitative Analysis  
Access to care. 
 
 One-half of the women in this project reported having a primary care provider (PCP). 
Seventeen (34%) women stated they were under the care of an OBGYN. When asked where care 
was received during episodes of illness, 17 (34%) women indicated care from a PCP, 14 (28%) 
women reported using the Emergency Department, and 3 (6%) reported staying home or not 
seeking care for an illness. Some women acknowledged the use of the Health Department, 
Emergency Department, low-income clinics, or methadone treatment facilities for preventative 
screenings such as Pap smears and STD testing. Access to care is illustrated in Figures 2, 3, and 
4.  All data related to access to care and health-seeking behaviors are available in Tables 2a and 
2b. 
Reproductive planning. 
  
 Of the 50 women surveyed, 45 (90%) had experienced at least one pregnancy and forty-
two women (84%) reported experiencing at least one unplanned pregnancy. Figure 5 
demonstrates the number of unplanned pregnancies among women who reported having ever 
been pregnant. Age at first pregnancy ranged from 13 to 30 years, with a mean of 20 years. At 
the time of the unplanned pregnancy, 24% of the women reported using some form of birth 
control and 60% reported they were not using any birth control. At the time of the survey, the 
majority of women (92%) indicated they were not trying to become pregnant, and 68% stated 
they were actively preventing pregnancy. All data related to reproductive history and pregnancy 
intentions may be found in Tables 3a and 3b.  
Contraceptive knowledge and behavior. 
 
 Overall, greater than 50% of the women indicated awareness of condoms, oral 
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contraceptive pills, intrauterine devices (IUD), Depo Provera injections, and withdrawal as 
primary forms of pregnancy prevention. Thirty-nine women (78%) acknowledged the IUD, and 
20 women (40%) reported the implant as a potential birth control method without prompting. In 
the past month, two women (4%) used the IUD as their primary form of birth control, and one 
woman (2%) indicated use of the implant during this time. These rates were considerably lower 
than other contraceptive selections including; sterilization for women (26%), abstinence (20%), 
and condoms (12%). Twenty-two percent of women reported not using any form of birth control. 
All data related to contraceptive knowledge and behavior may be found in Tables 4a and 4b. 
LARC awareness and perceptions. 
  
 When asked directly, 100% of the women reported that they had heard of the IUD. 
Comparatively, 74% of the women indicated they had heard of the implant. Perceptions of 
efficacy, safety, and cost, along with perceived rates of STDs, side effects, and unintended 
pregnancy for both IUD and implant are found in Figures 6 and 7. Eighty-two percent of 
participants reported that they have known at least one woman who used an IUD. However, only 
62% knew at least one woman reported a positive experience with the IUD. Likewise, while 52% 
of the women in this study reported that they knew least one woman who used had an implant, 
only 40% knew women who acknowledge a positive experience with the implant. Overall, 58% 
of the women stated they agreed or strongly agreed when asked if they would consider using an 
IUD. Fifty-four percent of the women agreed or strongly agreed that they would consider using 
the implant. All information related to LARC awareness and perceptions may be found in Table 
6. 
Qualitative Analysis 
Perceived benefits and barriers to LARC. 
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 Qualitative analysis using an open-coding approach to naming abstract concepts was used 
to analyze the free-text interview responses for all 50 women, and revealed 21 themes related to 
the increased or decreased likelihood of uptake of LARC. Some responses included more than 
one theme, in which case these participant responses were given more than one code. Responses 
of “I don’t know” for both the IUD (2) and the implant (2) were removed from analysis, as they 
did not provide insight into the question at hand. Eight women (16%) recognized no need for a 
current contraceptive method due to a history of a hysterectomy or a bilateral tubal ligation. 
However, these answers were not removed from analysis as many of these participants offered 
input related to their personal experience of either device. After themes were finalized, themes 
were then organized using concepts found within the Health Belief Model. All identified themes, 
the frequency at which they occurred, and corresponding exemplars are found in Table 2.  
Perceived benefits. 
 Three identified themes reflected the HBM core concept of “perceived benefits”. These 
themes described benefits to the use of either an IUD or an implant, including perceived 
effectiveness of either device, positive experiences with either device, and the ability to maintain 
normality. Maintaining normality was identified as a perceived benefit when the woman 
associated her ability to maintain a regular menstrual cycle as a favorable side effect of the 
device. Perceived effectiveness included concepts such as reliability, and maintenance of a non-
pregnant status. Positive experiences were coded as such when women noted an absence of side 
effects or complications.  
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Perceived barriers.  
Thirteen identified themes reflected the HBM core concept of “perceived barriers”. Each 
of these themes was presented as a reason to not use either an IUD or an implant. Twenty women 
(40%) reported a fear of complication related to the use of these devices. Fears included physical 
side effects such as bleeding, pain, displacement of the device, or the need for surgical removal if 
the device was misplaced. Fear also included failure of the device to prevent pregnancy or cause 
miscarriage. Fear of complications also involved concern for interference with sexual intercourse 
both physically and psychologically. Fear of complications was identified more frequently 
among those discussing the IUD (30%), compared to those discussing the implant (10%). 
Conversely, four women reported having actually experienced complications when they had used 
a LARC in the past. Because these complications were lived experiences for the women 
themselves, they were coded separately as lived complications. Twelve women (24%) cited a 
discomfort with the idea of a foreign object being inserted into the body. This unease was cited 
equally among those considering the IUD (12%) and the implant (12%). Eleven women (22%) 
cited a lack of knowledge when asked whether they would or would not use a LARC at this time. 
Lack of knowledge was coded when women made statements such as “…I don’t know a lot 
about it…” or “…I’ve never heard of it…”. Lack of knowledge was coded with eight women 
(16%) discussing the implant and three women (6%) discussing the IUD. A procedural barrier 
theme was identified when the woman referred to the process of insertion or removal of either 
device. There were an increased number of responses coded as procedural barrier when referring 
to the implant (10%) compared to the IUD (4%). Additional themes identified as perceived 
barriers to LARC uptake were; method preference (8%), perceived contraindication (6%), 
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delayed acquisition (2%), fear of change (2%), concern for delayed pregnancy (2%), financial 
barrier (6%), competing options (2%), and maintaining normality (2%). 
Perceived seriousness. 
One theme was subsumed under the core concept of “perceived seriousness”. Eight 
women reported statements indicating their desire for pregnancy as a reason for not using an 
IUD, an implant, or both at this time. Desire for pregnancy was interpreted in responses 
indicating both an active conscious attempt to conceive, and the ambivalence of preventing 
pregnancy demonstrated through statements such as “…we are not not trying to get pregnant…”. 
This theme, pregnancy intention, was categorized under the HBM concept of “perceived 
seriousness”, with the understanding that in the context of this project, a desire to become 
pregnant indicates a decrease in the perceived severity of an unintended pregnancy.  
Perceived susceptibility. 
One identified theme echoed the HBM core concept of “perceived susceptibility”. Eight 
women reported they did not believe they were in need of birth control at the time of the survey. 
These statements were assigned the theme of low perceived risk. Low perceived risk was 
categorized within this HBM concept, as these women did not believe they were at risk for, or 
susceptible to an unintended pregnancy. Women’s references to little or no sexual activity, 
increased age, and perceived decreased fertility levels were coded as indicators of low perceived 
risk.  
 Cues to action.  
 Two identified themes were categorized under the HBM concept “cues to action”. Fifteen 
women (30%) indicated that they had received information about the IUD or implant from their 
friends or family. These phrases were coded relationship influence and categorized within the 
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“cues to action” concept, as these anecdotes appeared to influence whether or not the woman was 
likely to use a LARC in the future. Similarly, two women (4%) noted the influence of 
professional recommendation by a healthcare provider. This theme was placed under the same 
concept.  
 Additional themes. 
 Seven women reported answers that led the project team to believe they were open to the 
possibility of using a LARC in the future. These answers included phrases such as “…I haven’t 
talked to my doctor yet…”, “…I would use the Mirena, I just haven’t asked for it yet…”, and 
“…I haven’t had a chance to use it…”. The theme of open possibility did not fit neatly within the 
concepts of the HBM, and as such was included as an additional theme in Table 2.  
Discussion  
 The women in this project reported an unintended pregnancy rate of 84%, almost twice as 
high as the rates found in both state and national statistics (CDC, 2015; Tennessee Department of 
Health, 2011). However, when compared to the rates of unintended pregnancy found among 
women with substance use disorders, these findings remain consistent (Black & Day, 2016). 
Although 66% of these women indicated that they were actively trying to avoid pregnancy at the 
time of the survey, they also reported low rates of continued birth control use, and decreased 
access to care in both primary care and gynecological services. In this setting, where the majority 
of the population communicates a clear intention to prevent future pregnancy, there is a distinct 
lack of engagement in evidence-based preventative actions. While women in the sample have 
committed themselves to a life of sustained recovery, yet this lifestyle remains threatened by the 
consequences of unintended pregnancy.  
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The threat of unintended pregnancy to sustained recovery is amplified by ineffective or 
inconsistent use of reliable contraception, and use of LARC among women in recovery from 
SUD could help them successfully achieve their intention to avoid pregnancy and support their 
commitment to recovery. However, at the time of this survey, only three women (6%) reported 
actively using a LARC. This low rate of LARC uptake is consistent with rates of uptake among 
women with substance use disorder found in the literature (Black & Day, 2016). To increase 
LARC use among women receiving MAT, it is imperative to understand and appropriately 
address the barriers women in this community describe. 
Perceived Barriers and Cues to Action 
 Of the themes identified as perceived barriers among women receiving MAT, the fear of 
complication related to the use of LARC was overwhelmingly prominent (40%), followed 
closely by foreign object (24%), and lack of knowledge (22%). These barriers are consistent with 
the barriers identified among women overall (Black & Day, 2016). However, according to the 
Health Belief Model, perceived barriers alone are not the only factors that influence the 
likelihood of engagement in preventative health behavior. The role of social influences, or cues 
to action, plays an equally persuasive part in the activation of health related behaviors (Abraham 
& Sheeran, 2015).  
 In this project, fifteen women (30%) indicated that they had learned information about 
LARC through the stories of others. Of these fifteen accounts, identified as relationship 
influence, fourteen were associated with one or more fears of complication. None of these 
fourteen women had used a LARC. In comparison, one woman did not associate relationship 
influence with fear of complication, but instead indicated she had received a LARC 
recommendation from her health care provider. This woman was actively using an IUD at the 
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time of the survey. Her response, “…My doctor recommended it. I’ve heard so many horror 
stories, but I’ve never had a problem…”, indicates that a professional recommendation initiated 
the uptake of the IUD, and despite accounts from others dispersed through the grapevine, her 
personal experience with the device was successful enough for method continuation. This 
suggests an untapped potential for circumventing the peer-influenced grapevine, through which 
unmitigated fears have spread.  
It is important to note, however, that though this woman cited a recommendation from 
her provider, only 50% of the women in this study noted access to a primary care provider, and 
34% cited access to an OBGYN. Therefore reliance on information from providers alone may 
not be sufficient to overcome the barriers shaped by social cues. As such, there is a need to create 
well-informed, educational, grassroots messaging that supplies women in MAT with the 
intellectual autonomy to choose LARC.  
Modifying Cues to Action 
 In order to break the cycle of negative news heard through the grapevine, it is essential to 
create and support appropriate health campaigns aimed at creating awareness, appropriately 
informing, and inciting contraceptive choice among women. Campaigns such as South 
Carolina’s “Keep Calm and LARC On”, the Colorado Initiative to Reduce Unintended 
Pregnancies, and the Iowa Initiative to Reduce Unintended Pregnancies, have been developed to 
provide increased provider training, decrease LARC cost, and create social marketing campaigns 
geared towards adolescents and college students (Association of State and Territorial Health 
Officials [ASTHO], 2014). These social marketing campaigns were used to increase awareness, 
decrease discomfort, and dispel the myths surrounding LARC use through outlets such as social 
media, brochures, info graphics, and promotional videos (Sundstrom, Billings, & Zenger, 2016).  
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 The successes of these campaigns suggest that similar forms of outreach may be 
beneficial in breaking down barriers when initiated within medication-assisted treatment 
facilities. Studies suggest that the provision of contraceptive counseling within MAT facilities 
may help break down barriers to access for women in treatment (Black & Day, 2016, Terplan et 
al., 2015). Though some treatment facilities may not be equipped to provide contraceptive 
services onsite, the provision of educational and professional resources at these sites may begin 
to bridge the gap between theoretical knowledge and actual LARC engagement. Because most 
MAT clients experience frequent access to treatment facilities, the implementation of awareness 
campaigns appropriately designed increase knowledge of LARC and decrease fears related to 
complication myths may increase contraceptive autonomy and the likelihood of LARC uptake 
among women in MAT.  
Limitations 
There are limitations to this study. The sample of 50 women was only 15% of the 
potential female population one medication-assisted treatment facility within the state of 
Tennessee.. As such, the views and experiences expressed by these women may not be an 
accurate representation of the entire clinic population, and can certainly not be generalized to all 
women using MAT to recover from active SUD.. The semi-structured interview style of this 
project alongside the sensitive nature of this subject may have contributed to social desirability 
bias related to women’s discomfort when reporting accurate answers to the interviewer. 
Conclusion 
 
 While the rates of unintended pregnancy remain high in the United States, there remains 
a great need to encourage contraceptive choice and reproductive autonomy among women 
receiving medication-assisted treatment for substance use disorder. Doing so represents a 
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commitment to women’s health, sustained sobriety, and a strategy for primary prevention of 
neonatal abstinence syndrome. The introduction of grassroots marketing campaigns within 
treatment facilities, alongside appropriate access to professional resources, creates the possibility 
to decrease antagonistic cues to action and the additional barriers related to uptake of LARC. 
With increased awareness, appropriate knowledge of, and perceived benefits to LARC, women 
in MAT may be able to successfully navigate their commitment to sustained recovery by 
decreasing unintended pregnancy through their informed choice of long-acting reversible 
contraception.  
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Figures  
 
 
Figure 1. The Health Belief Model. (Dadgarmoghaddam, M. et al.,2016).  
 
 
 
 
 
 
Figure 2. Locations utilized for treatment of illness among women enrolled in medication-
assisted therapy. (N=50). 
 
 
34%
28%
18%
10%
6%
2% 2%
Sick Care Locations
Primary Care Provider
Emergency Department
Walk-In/Retail
Urgent Care
Stay Home
Health Department
Other
The Health Belief Model 
Modifying 
Vari ables 
Perceived 
Seriousness 
Perceived 
Susceptibilit y 
Perceived Benefits vs. 
Perceived Barriers 
Perceived Threat 
Self-Efficacy 
Cues to A ction 
Likelihood of Engaging in 
Health- Promoting 
Be havior 
• 
II 
• 
II 
• 
• 
Running header: PERCEIVED BARRIERS TO LARC 
 
36 
 
 
Figure 3. Locations utilized for Pap smears among women enrolled in medication-assisted 
therapy. (N=50). 
 
 
 
 
 
 
 
Figure 4. Locations utilized for STD testing among women enrolled in medication-assisted 
therapy. (N=50). 
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Figure 5. Number of pregnancies, planned and unplanned, among women at a medication-
assisted treatment clinic in Nashville, Tennessee. (N=50) 
 
 
 
 
 
 
Figure 6. Participant perceptions of the IUD, captured using a 5-point Likert scale for each 
concept. Concepts include efficacy, safety, and cost of the device, as well as rates of STDs, side 
effects, and unintended pregnancy when the device is in use.  
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Figure 7. Participant perceptions of the Implant, captured using a 5-point Likert scale for each 
concept. Concepts include efficacy, safety, and cost of the device, as well as rates of STDs, side 
effects, and unintended pregnancy when the device is in use. 
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Tables 
 
Table 1. Sample demographics of women in medication-assisted treatment for opioid use 
disorder in Nashville, Tennessee (N=50).  
 
Characteristic n (%) 
Age (years)   
22-29 12 (24%) 
30-39 28 (56%) 
40-49 10 (20%)  
Ethnicity   
African American/Black 5 (10%) 
Hispanic/Latino 2 (4%)  
White 41 (82%)  
Native American/ American 
Indian 1 (2%) 
Asian/Pacific Islander 1 (2%)  
Education   
Some High School 7 (14%) 
High School or GED 10 (20%) 
Some college 26 (52%) 
Associate's Degree 3 (6%) 
Bachelor's Degree 3 (6%) 
Master's Degree 1 (2%)   
Marital Status    
Single 21 (42%) 
Married 14 (28%)  
Divorced 13 (26%) 
Separated 2 (4%) 
Income Source   
Unemployed 5 (10%) 
Unemployed with 
Government Assist 3 (6%) 
Part-Time 5 (10%) 
Full-Time 22 (44%)   
Other  15 (30%) 
Household Income   
0-$10,000 5 (10%)  
$10,001-$20,000 8 (16%) 
$20,001-$30,000 10 (20%) 
$30,001-$50,000 10 (20%)  
>$50,000 11 (22%)   
I don’t know 6 (12%)  
Insurance   
Employer  11 (22%) 
Insurance Company Direct 2 (4%) 
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Medicaid/Medicare 20 (40%) 
Other  17 (34%)  
 
 
 
Table 2. Identified themes related to the increased or decreased likelihood of LARC uptake 
among women receiving medication-assisted treatment for opioid use disorder in Nashville, 
Tennessee.  
 
Health Belief Model 
Concepts 
Identified Themes for both IUD & 
Implant  
Examples  
Perceived Benefits  Perceived Effectiveness (n = 4) "It's the most reliable with the 
least amount of maintenance. 
It seems to have the least 
amount of side effects"                                                                                                                                                        
"...I did use the IUD for five 
years. It worked. I got it after 
my 16 year-old-pregnancy..." 
 
  Positive Experience (n = 3) "…I've never had a problem 
with it. I've heard so many 
horror stories, but I've never 
had a problem..." 
  Maintaining Normality (n=1)    
Perceived Barriers Fear of Complication  (n=20)  "I had a friend who had it get 
stuck - it moved.  
She had to go get surgery. 
Ever since it happened it 
freaked me out"                                 
"I heard that it made women 
really sick, a lot of side effects 
and problems with having an 
implant in your arm. And I've 
heard women got pregnant 
while using this."                                     
"I couldn't get on board with 
it. I kept picturing it stabbing 
me. What if it's too big? What 
if it gets lost?" 
 
  Foreign Object (n= 12) "I wouldn't like the idea of 
something being inserted 
inside me"                                                 
"It's just kind of weird. I don't 
think I would want something 
up underneath my skin." 
Running header: PERCEIVED BARRIERS TO LARC 
 
41 
 
  Lack of Knowledge (n=11) "I don't know a lot about it"                                   
"I have never heard of it 
before"                          
 "...I haven't done my 
research…" 
  Procedural Barrier (n = 7) "I have an eversion to needles 
in general. I couldn't get on 
board. I didn't want to put 
something inside me."                                             
"…I don't know. It's just scary 
how they take it out…" 
 
  Method Preference (n=4) "I just always used the pill. It 
always worked for me"                                                                                
"I would just prefer to take a 
pill, it seems kind of drastic" 
 
  Complication (n = 4) "...I stopped using the IUD 
because I never stopped 
bleeding. It would stop for a 
short time and then start right 
back…" 
 
  Perceived Contraindication (n= 3) "I had endometriosis. I 
thought it would not be a good 
idea" 
  Delayed Acquisition (n= 1)   
  Fear of Change (n = 1)   
  Concern for Delayed Pregnancy  (n=1)   
  Financial Barrier (n = 3) "It was not offered on my 
insurance"                          
"The pill was free so I didn't 
look into it" 
  Competing Options (n = 1)   
  Maintaining Normality (n=1)   
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Perceived 
Seriousness 
Pregnancy Intention (n= 8) "I thought about it, but I 
thought for a long time. Now 
that I'm at this age, I wouldn’t 
mind getting pregnant soon. 
I'm just gunna wait and do 
condoms for now"                                                    
"I was thinking about maybe 
getting pregnant in the near 
future" 
Perceived 
Susceptibility 
Low Perceived Risk (n= 8)              "I've heard about it, but I don't 
have a lot of sex. So I don't 
think about what I should 
use."            
"I just don’t feel like at my 
age I would need it, i probably 
am not going to be fertile for 
very much longer any way." 
Cues to Action  Relationship Influence (n= 15) "Every woman I've talked to 
have had some complications 
and had to get it out, was 
hurting them, or it had to be 
taken out, they started 
bleeding - some type of 
complication"    
 "...I would not use an IUD 
because both the women I 
knew who used one got 
pregnant...”                                              
 
  Professional Recommendation (n = 2) "…Just because it's reliable, 
safe. My doctor recommended 
it…" 
Additional Theme                  
(Does not coincide 
within Health Belief 
Model Concepts) 
Open to Possibility  "…I need to make the time to 
go do it. Between drug use 
and life, it didn't seem like a 
priority…"    
"…I would want to learn 
more…" 
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Table 3a. Access to health care providers and preferred locations for treatment of illness among 
women in a medication-assisted treatment clinic in Nashville, Tennessee. (N=50). 
 
Access to Care  n (%) 
Primary Care Provider    
Yes  25 (50%) 
No  22 (44%) 
Other 3 (6%) 
Sick Care   
Primary Care Provider 17 (34%) 
Emergency Department 14 (28%) 
Walk-In/Retail 9 (18%) 
Urgent Care  5 (10%) 
Other  5 (10%) 
OBGYN 
 Yes 17 (34%) 
No 31 (62%) 
Other 2 (4%)  
 
 
Table 3b. Health behaviors of women in a medicated-assisted treatment clinic in Nashville, 
Tennessee. (N=50). 
 
Health Behaviors 
n (%) or mean +/- 
standard deviation 
Pap Test   
Yes  50 (100%) 
No 0 
Time since last Pap Test  2.68 years (+/- 2.24) 
Pap Test Location   
Primary Care Provider  6 (12%) 
OBGYN 15 (30%) 
Sexual Health Clinic 2 (4%) 
Other 11 (22%) 
Health Department 5 (10%) 
Emergency 
Department/Women’s Hospital 3 (6%) 
Low-Income Clinic 2 (4%) 
In-Patient Rehabilitation 1 (2%) 
STD Test    
         Yes 49 (98%) 
No 1 (2%) 
Time since last STD Test   3.61 years (+/- 3.61) 
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STD Test Location   
         Primary Care Provider 6 (12%) 
OBGYN 15 (30%) 
Sexual Health Clinic 2 (4%) 
Does Not Apply  1 (2%) 
Other 26 (52%) 
Health Department     8 (16%) 
         Methadone Clinic 8 (16%) 
         Emergency Department/ 
         Women's Hospital 4 (8%) 
         Low-Income Clinic 3 (6%) 
         In-Patient Rehabilitation 2 (4%) 
        Unknown 1 (2%) 
Mammogram   
        Yes 16 (32%) 
No 32 (64%) 
Don't Know 1 (2%) 
Declined to Answer 1 (2%) 
Time since last Mammogram  1.71 years (+/- 3.50) 
Smoke Cigarettes    
         Yes 40 (80%) 
No 8 (!6%)  
Quit  2 (4%) 
 
 
Table 4a. Reproductive history of women in a medication-assisted treatment clinic in Nashville, 
Tennessee. (N=50). 
 
Reproductive History 
n (%) or mean +/-  
standard deviation 
Ever Pregnant   
Yes 45 (90%) 
No 5 (10%) 
Age of 1st Pregnancy 20 years (+/- 3.55) 
Number of Pregnancies 2.9 ( +/- 1.56)  
Unplanned Pregnancy   
Yes 42 (84%) 
No 4 (8%) 
Does Not Apply 4 (8%) 
Using Birth Control    
Yes 12 (24%) 
Running header: PERCEIVED BARRIERS TO LARC 
 
45 
No 30 (60%) 
Does Not Apply  7 (14%)  
Declined to Answer 1 (2%) 
Trouble Accessing Birth Control   
Yes 6 (12%) 
No 43 (86%) 
Have not tried to Access 1 (2%) 
 
 
Table 4b. Pregnancy intentions of women in a medication-assisted treatment clinic in Nashville, 
Tennessee. (N=50). 
 
Pregnancy Intentions n (%) 
Trying to get Pregnant   
Yes 4 (8%) 
No 46 (92%) 
Want to be Pregnant   
Strongly Disagree 28 (56%) 
Disagree 7 (14%) 
Neutral  8 (16%) 
Agree 7 (14%) 
Strongly Agree 0 
Wouldn't Mind Being Pregnant   
Strongly Disagree 19 (38%) 
Disagree 4 (8%) 
Neutral  12 (24%) 
Agree 15 (30%) 
Strongly Agree 0 
Trying to Avoid Pregnancy   
Strongly Disagree 1 (2%) 
Disagree 8 (16%) 
Neutral  8 (16%) 
Agree 6 (12%) 
Strongly Agree 27 (54%) 
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Table 5a. Behaviors related to the use of Oral Contraceptives, Depo Provera Injections, and 
Condoms as primary birth control methods. (N=50)  
 
Birth Control Methods  n (%) 
Oral Contraceptives   
Used   
Yes 44 (88%) 
No 6 (12%) 
Missed a Dose    
Yes 6 (12%) 
No 38 (74%) 
Does Not Apply 6 (12%) 
Depo Provera Injection   
Used   
Yes 27 (54%) 
No 23 (46%) 
Missed a Dose    
Yes 1 (2%) 
No 39 (78%) 
Does Not Apply 10 (20%)  
Condoms   
Used   
Yes 49 (98%) 
No 1 (2%) 
Decided Not to Use   
Yes  35 (70%)  
No 14 (28%) 
Does Not Apply 1 (2%) 
Discomfort Asking Partner   
Yes 10 (20%) 
No  39 (79%) 
Does Not Apply 1 (2%) 
Partner Refusal   
Yes 6 (12%) 
No  43 (86%) 
Does Not Apply 1 (2%) 
Purpose   
Prevent STDs 7 (14%) 
Prevent Pregnancy 5 (10%) 
Both 37 (74%)  
Does Not Apply 1 (2%) 
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Table 5b. Awareness of and actual use of contraceptive methods by women enrolled in a 
medication-assisted treatment clinic. Participants were able to select more than one answer for 
each question. 
 
Birth Control I've 
Heard Of n (%) 
Birth Control I've Used in the 
Last Month n (%) 
Condom 40 (80%) Condom 6 (12%)  
Oral Contraceptive 
Pills 
46 (92%)  Oral Contraceptive Pills 2 (4%)  
IUD/IUS 39 (78%)  IUD/IUS 2 (4%)  
Depo-Provera 34 (68%) Depo-Provera 2 (4%)  
Implant (Implanon) 20 (40%)  Implant (Implanon) 0 
Withdrawal 26 (52%) Withdrawal 4 (8%)  
Sterilization for men  5 (10%)  Sterilization for men  1 (2%)  
Sterilization for women  11 (22%) Sterilization for women  13 (26%)  
Safe period/Rhythm 
Method 
2 (4%)  Safe period/Rhythm Method 0 
Diaphragm/Cap 12 (24%)  Diaphragm/Cap 0 
   None, I am not sexually active 10 (20%)  
Other  34 (68%)  Other  18 (36%)  
Nuva Ring 7 (14%) None, I am sexually 
active  
11 (22%) 
Spermicide  10 (20%)  Spermicide 1 (2%)  
Sponge 9 (18%)  Hysterectomy/ 
Tubal Ligation 
4 (8%)  
Film/Foam 4 (8%)     
Plan B Pill 4 (8%)      
Patch 8 (6%)      
Dental Dam 1 (2%)     
E-Sure 
Procedure 
1 (2%)      
Abstinence  9 (18%)      
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Table 6. Awareness and observation of IUDs and Implants. (N=50). 
 
IUD n (%) Implant n (%) 
Heard of   Heard of   
Yes 50 (100%) Yes 39 (78%) 
No 0 No 9 (18%) 
    I Don't Know 2 (4%) 
Know Women Who Used It   Know Women Who Used It   
None 9 (18%) None 24 (48%) 
A Few 24 (48%) A Few 20 (40%) 
More Than A Few 17 (34%) More Than A Few 6 (12%) 
All 0 All 0 
Know Women Who Liked It   Know Women Who Liked It   
None 19 (38%) None 30 (60%) 
A Few 20 (40%) A Few 16 (32%) 
More Than A Few 9 (18%)  More Than A Few 4 (8%) 
All 2 (4%) All 0 
I would consider using the IUD   I would consider using the Implant 
Strongly Disagree 10 (20%) Strongly Disagree 5 (10%) 
Disagree 5 (10%) Disagree 11 (22%) 
Neutral  6 (12%) Neutral  7 (14%) 
Agree 23 (46%) Agree 25 (50%) 
Strongly Agree 6 (12%) Strongly Agree 2 (4%) 
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Appendix  
 
Adapted Survey 
 
SCRIPT: Thank you so much for agreeing to participate in this women’s health and birth 
control survey. I really appreciate your time. Over the next few minutes I will be asking you 
some questions about to your personal health, the health care you receive, and some specific 
questions about birth control. When I say birth control I am referring to any way you would 
prevent pregnancy including pulling out, condoms, the pill, the shot, the patch, IUDs, implants, 
or sterilization. You do not have to answer the questions you don’t want to. Please stop me at 
any time if you have questions about what I say. I am happy to answer any questions and repeat 
any information. Everything we say during this session is confidential, including all of your 
answers and any personal information. At the end of this survey you will receive your gift card. 
Are you ready to get started? 
 
Section I: Access to Care. I’d like to start by asking you a few questions about to your health 
care. 
 
1.  Do you have a Primary Care Provider? 
 a.  Yes 
 b.  No  
 c. Other (please specify) 
  ___________________________________ 
 
2.  Do you have an OBGYN? 
 a.  Yes  
 b.  No 
 c.  Other (please specify)  
  ___________________________________ 
 
3 . If you are sick, where do you go for care? 
 a.  My Primary Care Provider 
 b.  Retail Health Clinic/Walk-In Clinic 
 c.  Urgent Care  
 d.  The Emergency Department 
 e.  Other (please specify) 
  ___________________________________ 
 
4. Have you ever had a pap test?  
 a.  No 
 b.  Yes  
 c.  Don’t know  
 d.  Decline to answer 
 
5. If yes, when was the last time? (When was your last one?) 
 ___________________________ weeks/months/years 
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6. If yes, where was it performed? (Where did you get it?) 
 a. Primary Care Provider Office  
 b. OBGYN Office  
 c. Sexual Health Clinic  
 d. Other (please specify): 
 _______________________________ 
 e. Does not apply (I have not had a pap test) 
 
7. Have you ever been screened for sexually transmitted infections? (Have you ever been tested 
for an STD?) 
 a.  No 
 b.  Yes  
 c.  Don’t Know 
 d. Decline to Answer  
 
8.  If yes, when was the last time? (When was the last time?) 
 ___________________________ weeks/months/years 
 
9.  If yes, where was it performed? (Where did you have it done?) 
 a. Primary Care Provider Office  
 b. OBGYN Office  
 c. Sexual Health Clinic  
 d. Other (please specify): 
 _______________________________ 
 e. Does not apply (I have not had an STD test) 
 
10.  Have you ever had a mammogram? 
 a.  No 
 b.  Yes  
 c.  Don’t Know 
 d. Decline to Answer  
 
11.  If yes, when was the last time? (When was the last time?) 
 ___________________________ weeks/months/years 
 
12. Do you smoke cigarettes?  
 a.  No 
 b.  Yes 
 c. I used to, but I have quit 
 d.  Decline to answer 
 
SECTION II: Reproductive Planning. These next few questions are about pregnancy and 
plans for pregnancy 
 
13. Have you ever been pregnant? 
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a. No 
b. Yes, in the past 
c. Yes, currently pregnant 
d. Declined to Answer 
 
14. If yes, how many times have you been pregnant? (How many times?) 
 _________________________ (times)  
a. Does not apply (I have never been pregnant)  
 
15. How old were you when you first became pregnant? 
 _______________________ (years) 
a. Does not apply (I have never been pregnant)  
 
16. Have you ever experienced a pregnancy that wasn’t planned?  
a. No 
b. Yes 
c. Declined to Answer 
d. Does not apply (I have never been pregnant) 
 
17. If you have experienced a pregnancy that wasn’t planned, were you using contraception 
(birth control) at that time? (Were you using any birth control at the time of your unplanned 
pregnancy?) 
 a. No 
 b. Yes 
 c. Declined to Answer 
 d. Does not apply (I have never been pregnant)  
 
18. If you were using contraception (birth control), what method(s) were you using? 
 ______________________________ (free text)  
 
19.  Have you been trying to get pregnant in the last 12 months? 
a. No 
b. Yes  
c. Declined to Answer  
 
20. Have you had any difficulty accessing services for contraception? (Have you ever had a 
problem getting birth control?) 
a. Yes 
Please explain ______________________________ 
b. No 
c. I haven’t tried to access these services  
 
 
Please select the most appropriate answer for the following statements. I am going to read 
you a few sentences about pregnancy. I would like you to tell me if you Strongly Disagree, 
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Disagree, are Neutral, Agree, or Strongly Agree with each sentence. You are welcome to use this 
visual guide to help you see the answers to choose from. 
 
 
21. I want to be pregnant in the next year. 
 
____Strongly Disagree   ____Disagree   ____ Neutral   ____ Agree   ____ Strongly Agree 
 
22. I wouldn’t mind if I was pregnant in the next year. 
 
____Strongly Disagree   ____Disagree   ____ Neutral   ____ Agree   ____ Strongly Agree 
 
23. I am trying to avoid pregnancy in the next year.   
 
____Strongly Disagree   ____Disagree   ____ Neutral   ____ Agree   ____ Strongly Agree 
 
24. I feel that I should always use contraception (birth control) when having intercourse (sex). 
 
____Strongly Disagree   ____Disagree   ____ Neutral   ____ Agree   ____ Strongly Agree 
 
25. It is okay for my counselor to talk to me about contraception (birth control). 
 
____Strongly Disagree   ____Disagree   ____ Neutral   ____ Agree   ____ Strongly Agree 
 
Section III: Contraceptive Knowledge and Behavior. These next few questions are about birth 
control. 
 
26. Could you please list the types of birth control that you have heard of? (Mark all that apply) 
 _____  Condoms 
 _____ Oral contraceptive pills  
 _____  IUD/IUS 
 _____ Depo-Provera 
 _____ Implant (Implanon) 
 _____ Withdrawal 
 _____ Sterilization for men  
 _____ Sterilization for women 
 _____ Safe period/Rhythm method  
 _____ Diaphragm/cap 
 _____ Other (please specify): 
  ____________________________ 
 _____ Declined to answer  
 
27. What types of birth control have you used in the past month? (Mark all that apply) 
 _____  Condoms 
 _____ Oral contraceptive pills 
 _____  IUD/IUS 
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 _____ Depo-Provera 
 _____ Implant (Implanon) 
 _____ Withdrawal 
 _____ Sterilization for men (Vasectomy)  
 _____ Sterilization for women (Bilateral Tubal Ligation) 
 _____ Safe period/Rhythm method  
 _____ Diaphragm/cap 
 _____ None, I am not sexually active 
 _____ Other (please specify): 
  ____________________________ 
 _____ Declined to answer  
 
28. Have you ever taken the pill? 
 a. No 
 b. Yes 
 c. Declined to Answer  
 
29. While you were taking the pill did you ever forget or miss a dose?  
 a. No  
 b. Yes  
 c. Declined to Answer 
 d. Does not apply (I have never taken the pill)  
 
30. If you have chosen not to use the pill, please say why: 
 ____________________________________ (Free Text) 
 
31. Have you ever used a condom? 
 a. No  
 b. Yes  
 c. Declined to Answer  
 
32. When you were using condoms, did you ever forget or decide not to use one? 
 a. No  
 b. Yes  
 c. Declined to Answer  
 d. Does not apply (I have never used a condom) 
 
33. Have you ever not used a condom because you were uncomfortable asking your partner to 
use one? 
 a. No 
 b. Yes 
 c. Declined to Answer  
 d. Does not apply (I have never used a condom) 
 
34. Have you ever not used a condom because your partner refused to use one? 
 a. No  
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 b. Yes 
 c. Declined to Answer  
 d. Does not apply (I have never used a condom) 
 
35. When you were using condoms were you primarily using them to prevent pregnancy, to 
prevent sexually transmitted diseases (STDS), or both? 
 a. To prevent pregnancy 
 b. To prevent STDs 
 c. Both  
 d. Declined to answer  
 e. Does not apply (I have never used condoms) 
 
36. If you have ever chosen not to use a condom for another reason, please say why: 
 ____________________________________ (Free Text) 
 
37. Have you ever used the Depo shot (also called Depo Provera) for birth control?  
 a. No 
 b. Yes 
 c. Declined to Answer 
 
38.  While you were using the shot did you ever forget or miss a dose?  
 a. No  
 b. Yes  
 c. Declined to Answer 
 d. Does not apply (I have never used the shot)  
 
39. If you have chosen not to use the shot, please say why: 
 ____________________________________ (Free Text) 
 
Section IV: Intrauterine Devices. The next few questions are about the intrauterine device, or 
IUD. These devices have brand names such as the Mirena.  Skyla, Liletta, Kyleena, and 
Paragard. When I say IUD, I’m referring to any of these specific devices. 
 
40. Have you ever heard of the IUD? 
a. No 
b. Yes 
c. Not sure  
 
41. About how many women do you know who have used an IUD? 
 a.  None 
 b. A few 
 c.  More than a few  
 d.  All the women I know have used an IUD 
 
42. About how many women do you know who liked using the IUD? 
a. None 
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b. A few  
c. More than a few  
d. All the women I know liked using an IUD 
 
Please select the most appropriate answer for the following statements. The next few 
statements are about IUDs. I’d like you to tell me if you strongly disagree, disagree, are neutral, 
agree, or strongly agree with each statement. You are welcome to use guide to help you see the 
answers to choose from. 
 
43. I think women using IUDs are more likely to become pregnant than women using the pill to 
prevent pregnancy. 
 
____ Strongly Disagree  ____Disagree  ____ Neutral  ____ Agree ____ Strongly Agree 
 
44. I think IUDs cost more than the pill, when both are used for 3 years. 
 
____ Strongly Disagree  ____Disagree  ____ Neutral  ____ Agree ____ Strongly Agree 
 
45. I think women using IUDs are more likely to have side effects than women using the pill. 
 
____ Strongly Disagree  ____Disagree  ____ Neutral  ____ Agree ____ Strongly Agree 
 
46. I think women using IUDs are more to get sexually transmitted infections (an STD) than 
women using the pill. 
 
____ Strongly Disagree  ____Disagree  ____ Neutral  ____ Agree ____ Strongly Agree 
 
47. I believe IUDs are a safe form of birth control. 
 
____Strongly Disagree ____Disagree  ____ Neutral  ____ Agree ___ Strongly Agree 
 
48. I believe IUDs are a more effective/reliable form of birth control, compared to the pill. 
 
____Strongly Disagree ____Disagree  ____ Neutral  ____ Agree ___ Strongly Agree 
 
49. I would consider using an IUD for birth control. 
 
____Strongly Disagree ____Disagree  ____ Neutral  ____ Agree ___ Strongly Agree 
 
Section V: Implants. The next few questions are about the Implant. The implant is also called a 
Nexplanon. When I say Implant, I’m referring to this device. 
  
 
50. Have you ever heard of an Implant (or Nexplanon)? 
a. No 
b. Yes  
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c. Not Sure  
 
51. About how many women do you know who have used an Implant? (You may use this visual 
guide to help you choose your answer) 
 a.  None 
 b. A few 
 c.  More than a few  
 d.  All the women I know have used an Implant 
 
52. About how many women do you know who have were happy using an Implant? (You may 
use this visual guide to help you choose your answer) 
 
 a.  None 
 b. A few 
 c.  More than a few  
 d.  All the women I know have been happy using an Implant 
 
 
Please select the most appropriate answer for the following statements. The next few 
statements about implants. I’d like you to tell me if you strongly disagree, disagree, are neutral, 
agree, or strongly agree with each statement. You are welcome to use guide to help you see the 
answers to choose from. 
 
53. I think women using implants are more likely to become pregnant than women using the pill 
to prevent pregnancy. 
 
____ Strongly Disagree  ____Disagree  ____ Neutral  ____ Agree ____ Strongly Agree 
 
 
54. I think implants cost more than the pill, when both are used for 3 years. 
 
____ Strongly Disagree  ____Disagree  ____ Neutral  ____ Agree ____ Strongly Agree 
 
 
55. I think women using implants are more likely to have side effects than women using the pill? 
 
____ Strongly Disagree  ____Disagree  ____ Neutral  ____ Agree ____ Strongly Agree 
 
56. I think women using implants are more likely to get sexually transmitted infections than 
women using the pill. 
 
____ Strongly Disagree  ____Disagree  ____ Neutral  ____ Agree ____ Strongly Agree 
 
57. I believe implants are a safe form of contraception. 
 
____Strongly Disagree  ____Disagree  ____ Neutral  ____ Agree ____ Strongly Agree 
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58. I believe implants are a more effective/reliable form of contraception than the pill. 
 
____Strongly Disagree  ____Disagree  ____ Neutral  ____ Agree ____ Strongly Agree 
 
59. I would consider using an implant for contraception. 
 
____Strongly Disagree  ____Disagree  ____ Neutral  ____ Agree ____ Strongly Agree 
 
Section VI: Barriers to LARC. This next set of questions is related to reasons why you have or 
have not used an IUD or Implant.  
 
60. Have you ever thought about using the IUD or implant as a birth control method option but 
decided not to get one? 
a. Yes 
___________________ (If yes, please specify which one) 
b. No 
c. Declined to Answer 
d. Does not apply (I am currently using a LARC). 
 
61. Please tell me a little bit about your choice to use/or not use an IUD. 
Free Text: 
______________________________________________________________________________
____ 
 
62. Please tell me a little bit about your choice to use/or not use to use an Implant. 
Free Text: 
______________________________________________________________________________
____ 
 
Section VII: Demographics. This final set of questions include some general information about 
yourself.  
 
63. How old are you?  
 a. 18-21 
 b. 22-29 
 c. 30-39 
 d. 40-49 
 
64. What is the highest level of education you have completed? 
  a. Some High School  
 b. High School Diploma or GED 
 c. Some college credit, but did not graduate college 
 d. Associate’s Degree 
 e. Bachelor’s Degree  
 f. Master’s Degree or higher  
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65. What is your main source of income? 
 a. Unemployed 
 b. Unemployed and receiving government benefits 
 c. Part-time  
 d. Full-Time 
 e. Maternity leave  
 f. Other: ________________________ 
 
66. What is your approximate household income? 
a. 0 - $10,000  
b. $10,000 - $20,000 
c. $20,001 - $30,000 
d. $30,001 - $50,000 
e. > $50,000  
f. Don’t know  
 
67. What is your current marital status? 
 a. Single, never married 
 b. Married 
 c. Divorced 
 d. Separated, not divorced 
 e. Widowed 
 
68. Do you have insurance? If so what kind? 
 a. Insurance through a current or former employer or union  
  (by you or another member of your family) 
 b. Insurance purchased directly from an insurance company 
  (by you or another member of your family) 
c. Medicaid, Medical Assistance, or any kind of government-assistance plan for those 
with low incomes or a disability 
d. TRICARE or other military health care  
e. VA (including other those who have ever used or enrolled for VA health care) 
f. None 
g. Any other type of health insurance of health coverage plan 
 Specify: ________________________________ 
 
69. Please specify your ethnicity.  
 a. African American or Black 
 b. Hispanic or Latino 
 c. White  
 d. Native American or American Indian 
 e. Asian/Pacific Islander 
 f. Other  
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70. Finally, we would like to know how good or bad your health is today on a scale numbered 
from 0 to 100. If 100 means the best health you can imagine and 0 means the worst health you 
can imagine, please tell me a number that indicates your health today. 
 
____________________. 
You have reached the end of the survey. I am very grateful for your time. 
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Women’s Health Survey  
Be a part of an important women’s health survey! 
 Are you a woman between 18 and 44 years of age? 
 Are you interested in sharing your thoughts on women’s health and 
family planning? 
If you answered YES to these questions, you may be eligible to participate in a 
survey about women’s health and family planning. 
 
We want to understand how women taking methadone think about family planning. 
To thank you for your time, you will receive a $5 gift card to Kroger at the conclusion of the survey. 
No medication will be given. 
. 
The study will take place at Behavioral Health Group in Nashville, TN. 
From October 10th to November 3rd, 2017 
Please see your dosing nurse or counselor for more information
Running header: PERCEIVED BARRIERS TO LARC 
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Memo One (January 3rd 2018) 
Carleigh Smith 
Scholarly Project Results 
 
The process of identifying themes within the free text responses of this survey began on 
Wednesday, January 3rd. Prior to the start of this process, the project and survey tool were 
reviewed with Dr. Busby to provide an understanding of the reasoning behind the asking of 
Questions 60, 61, and 62. Each participant response was reviewed separately. Key words or 
phrases were identified and agreed upon in a joint effort to capture the participants’ thoughts.  
 
In Question 61, the first participant response yielded two possible themes: “Relationship-
Influence” & “Fear of Complications”. “Relationship-Influence” was identified through the use 
of the phrase “every woman I’ve talked to”. It was understood that this participant relied on 
feedback from others to help make her decisions. “Fear of complications” was identified through 
words including “complications”, “hurting them”, and “bleeding”. 
 
 Response 2 was coded as “Open to Possibility” as the statement “I haven’t talked to my doctor 
about it yet” indicated the participant may be willing to discuss the use of such as method but has 
not yet.  
 
Response 3 was coded “Fear of Complications (FOC)” and “Foreign Body”. “No Foreign Body” 
was taken from the statement “my body doesn’t like foreign things’. “FOC” was understood 
from the phrase “It pushes it out…”if…my body tried to push it out, where is it going to go?”.  
 
Response 4 included a participant that had previously used a Mirena (IUD). This was different 
from previous answers, as no one had yet to use the device in question. It was thought to note 
that the participant stated she had considered using BOTH devices, but has ultimately chosen the 
IUD. She has not used implant at the time of this survey. In response to her use of the IUD the 
participant noted she was “allowed to still have a period” which was coded as “Maintaining 
Normality” (it was also though that  “seeking neutrality” may be used). Additionally she 
mentioned “didn’t say anything about weight gain” this was then coded as “Lack of 
Complication”, as weight gain was not a problem for this participant.  
 
Response 5 was “I’m not sure” this was determined to be unhelpful in determining reasoning 
behind the use or non-use of an IUD and was set aside as a response. From this point, all “I’m 
not sure”, “I don’t know” or similar answers were set aside and not assigned codes.  
 
Response 6 was coded “Foreign Body” for the phrase “getting something put in me” this was 
determined to be similar to Response 3.  
 
Response 7 was coded “Open to Possibility” as the respondent noted “I would use…just haven’t 
asked for it”. This was similar in response to #2. The lack of conversation with the doctor – 
which seemed to have placed ownership of the participant themselves, not a provider’s refusal or 
inattention to the device.  
 
 
